PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Medroxyprogesterone acetate - Menopausal disorders

PAD Profile : Medroxyprogesterone acetate - Menopausal disorders Important

Keywords :
Menopause, menopausal symptoms, HRT, hormone replacement therapy, progesterone analogue, progestogen, adjunctive progestogen, endometrial protection
Brand Names Include :
Provera
Important Information :
10mg tablets for adjunctive progestogen therapy

Traffic Light Status

Status 1 of 1.

Status :
Green (see narrative)
Important
Formulations :
  • Tablets
Important Information :
2nd line for endometrial protection in women who have abnormal bleeding on other HRT.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

Type
Document
Review Date
Patient resource
Continuous Progesterone -Patient Information Leaflet - May 2024.pdf
01 October 2024
Webpage
NHS Hormone Replacement Therapy Prescription Prepayment Certificate (HRT PPC)

Committee Recommendations

No committee recommendations returned.

Associated BNF Codes

06. Endocrine System
06.04.01. Female sex hormones and their modulators
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More